Quantcast

Latest Drug Price Competition and Patent Term Restoration Act Stories

2014-05-27 16:25:33

DUBLIN, May 27, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Saxagliptin Hydrochloride Tablets, 2.5 mg and 5 mg. Actavis' ANDA product is a generic version of AstraZeneca and Bristol-Myers Squibb's Onglyza(®), which is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes....

2014-02-28 16:23:59

DUBLIN, Feb. 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Colchicine Tablets USP, 0.6 mg. Actavis' ANDA product is a generic version of Takeda's Colcrys(®), which is a prescription medicine used in adults to prevent and treat gout flares. Takeda Pharmaceuticals U.S.A., Inc. filed suit against Actavis on February 27, 2014 in the...

2014-02-28 08:25:23

DUBLIN, Feb. 28, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dronedarone Hydrochloride Tablets 400 mg. Actavis' ANDA product is a generic version of Sanofi's Multaq(®), which is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial fibrillation (AF) in patients in sinus rhythm with a history of...

2014-02-04 08:34:45

DUBLIN, Feb. 4, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Bendamustine Hydrochloride for Injection, 25 mg/vial and 100 mg/vial. Actavis' ANDA product is a generic version of Cephalon's Treanda(®), a treatment for chronic lymphocytic leukemia and non-Hodgkin's lymphoma. Cephalon, Inc. filed suit against Actavis on January 31,...

2014-01-29 12:28:09

WASHINGTON, Jan. 29, 2014 /PRNewswire-USNewswire/ -- "In last night's State of the Union address, President Obama said, 'Today in America... [a]rural doctor gave a young child the first prescription to treat asthma that his mother could afford,' vividly capturing the critical importance of access to safe, affordable medicines for our nation's patients and our health care system. Indeed, in the 30 years since the enactment of the enormously successful Hatch-Waxman law in 1984, which...

2014-01-14 08:23:03

WASHINGTON, Jan. 14, 2014 /PRNewswire/ -- Sterne, Kessler, Goldstein & Fox P.L.L.C., an intellectual property law firm based in Washington, DC, recently announced the election of four new directors - Paul A. Ainsworth, Salvador M. Bezos, Carla Ji-Eun Kim, and Lei Zhou- effective January 1, 2014. -- Paul A. Ainsworth is a director in the Litigation Practice Group. He represents clients in litigation in a diverse range of technologies and has extensive experience...


Word of the Day
tesla
  • The unit of magnetic flux density in the International System of Units, equal to the magnitude of the magnetic field vector necessary to produce a force of one newton on a charge of one coulomb moving perpendicular to the direction of the magnetic field vector with a velocity of one meter per second. It is equivalent to one weber per square meter.
This word is named for Nikola Tesla, the inventor, engineer, and futurist.